Table 2.
Laboratory profile
| Lipids | |
| TC (mg/dL) | 195 ± 37 |
| LDL-C (mg/dL) | 110 ± 30 |
| HDL-C (mg/dL) | 58 ± 17 |
| TG (mg/dL)a | 115 (86/150) |
| Non-HDL-C (mg/dL) | 137 ± 34 |
| MDA-LDL (U/L) | 109 ± 44 |
| Lp (a) (mg/dL)a | 11 (5/25) |
| RLP-C (mg/dL)a | 5.3 (4.0/7.7) |
| Apolipoproteins(mg/dL) | |
| apoA-1 | 147 ± 30 |
| apo B | 90 ± 21 |
| apo C-II | 4.5 ± 1.9 |
| apo C-III | 10.0 ± 3.3 |
| Inflammatory markers | |
| hs-CRP (mg/L)a | 0.5 (0.3/1.2) |
| PUFAs (μg/mL) | |
| EPAa | 63 (40/93) |
| DHAa | 129 (101/161) |
| AA | 163 ± 44 |
| EPA/AAa | 0.397 (0.246/0.608) |
TC total cholesterol, LDL low-density lpoprotein, HDL high-density lipoprotein, MDA malondialdehyde-modified, Lp lipoprotein, RLP remnant-like particle, apo apolipoprotein, hs-CRP hypersensitive C-reactive protein, PUFA polyunsaturated fatty acids, EPA eicosapentaenoic acid, DHA docosahexaenoic acid, AA arachidonic acid
aMedian; interquartile range in parentheses